SpringWorks Therapeutics Ownership 2024 | Who Owns SpringWorks Therapeutics Now?
Institutional Ownership
11.05%
Insider Ownership
2.02%
Retail Ownership
86.93%
Institutional Holders
73.00
SpringWorks Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 15.06% | 0.03% | 11,112,391 | 44,365 | 0.40% | 418,603,769 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.87% | 0.00% | 6,544,413 | 15,088 | 0.23% | 246,528,038 | Jun 30, 2024 |
| BLACKROCK INC. | 7.62% | 0.00% | 5,619,260 | 180,403 | 3.32% | 211,677,525 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.02% | 4.16% | 3,700,000 | 220,147 | 6.33% | 139,379,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.88% | 0.02% | 3,602,234 | -508,228 | -12.36% | 135,697,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 4.64% | 6.79% | 3,421,541 | - | - | 128,889,449 | Jun 30, 2024 |
| STATE STREET CORP | 4.18% | 0.01% | 3,086,845 | 125,221 | 4.23% | 116,281,451,000 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 3.53% | 1.86% | 2,600,524 | 691,894 | 36.25% | 97,961,739 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 3.16% | 0.12% | 2,333,117 | -633,505 | -21.35% | 87,888,517 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 2.81% | 0.26% | 2,073,970 | -243,840 | -10.52% | 78,126,000 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.31% | 1.28% | 1,707,331 | - | - | 64,315,159 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.24% | 1.48% | 1,652,962 | -609,500 | -26.94% | 62,267,079 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 2.20% | 0.73% | 1,624,991 | -97,386 | -5.65% | 61,213,411 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.20% | 0.07% | 1,619,842 | 3,684 | 0.23% | 61,018,851 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.12% | 0.01% | 1,561,058 | 56,355 | 3.75% | 58,816,242 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.85% | 0.49% | 1,362,399 | 495,175 | 57.10% | 51,321,570 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.78% | 1.26% | 1,313,026 | -102,322 | -7.23% | 49,461,689 | Jun 30, 2024 |
| FIERA CAPITAL CORP | 1.76% | 0.15% | 1,297,302 | 380,027 | 41.43% | 48,869,366 | Jun 30, 2024 |
| DUQUESNE FAMILY OFFICE LLC | 1.38% | 1.32% | 1,021,367 | 1,021,367 | 100.00% | 38,475,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.36% | 0.22% | 1,000,000 | 650,000 | 185.71% | 37,670,000 | Jun 30, 2024 |
SpringWorks Therapeutics's largest institutional shareholder is FMR LLC, holding 15.06% of the company's total share outstanding, currently valued at $418.60M. The top 10 institutional shareholders own together 59.77% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 0.32% | 8.20% | 233,200 | -188,383 | -44.68% | 8,784,644 | Jun 30, 2024 |
| FINEPOINT CAPITAL LP | 0.87% | 6.83% | 638,352 | 45,824 | 7.73% | 24,046,720 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 4.64% | 6.79% | 3,421,541 | - | - | 128,889,449 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 0.15% | 5.39% | 110,400 | - | - | 4,158,768 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.02% | 4.16% | 3,700,000 | 220,147 | 6.33% | 139,379,000 | Jun 30, 2024 |
| BRIDGER MANAGEMENT, LLC | 0.20% | 2.80% | 144,526 | - | - | 5,444,294 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 3.53% | 1.86% | 2,600,524 | 691,894 | 36.25% | 97,961,739 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.24% | 1.48% | 1,652,962 | -609,500 | -26.94% | 62,267,079 | Jun 30, 2024 |
| DUQUESNE FAMILY OFFICE LLC | 1.38% | 1.32% | 1,021,367 | 1,021,367 | 100.00% | 38,475,000 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.31% | 1.28% | 1,707,331 | - | - | 64,315,159 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.78% | 1.26% | 1,313,026 | -102,322 | -7.23% | 49,461,689 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 2.20% | 0.73% | 1,624,991 | -97,386 | -5.65% | 61,213,411 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.07% | 0.70% | 50,987 | - | - | 1,920,680 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.85% | 0.49% | 1,362,399 | 495,175 | 57.10% | 51,321,570 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.07% | 0.39% | 53,930 | - | - | 2,031,543 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.10% | 0.36% | 70,269 | - | - | 2,647,033 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.01% | 0.35% | 10,000 | - | - | 376,700 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.09% | 0.30% | 69,999 | -30,001 | -30.00% | 2,636,862 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.01% | 0.30% | 7,450 | - | - | 280,642 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 2.81% | 0.26% | 2,073,970 | -243,840 | -10.52% | 78,126,000 | Jun 30, 2024 |
The largest SpringWorks Therapeutics shareholder by % of total assets is ORACLE INVESTMENT MANAGEMENT INC. The company owns 233.20K shares of SpringWorks Therapeutics (SWTX), representing 8.20% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DUQUESNE FAMILY OFFICE LLC | 1.38% | 1.32% | 1,021,367 | 1,021,367 | 100.00% | 38,475,000 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 3.53% | 1.86% | 2,600,524 | 691,894 | 36.25% | 97,961,739 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.36% | 0.22% | 1,000,000 | 650,000 | 185.71% | 37,670,000 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 0.93% | 0.24% | 683,539 | 573,944 | 523.70% | 25,749,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.85% | 0.49% | 1,362,399 | 495,175 | 57.10% | 51,321,570 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.61% | 0.01% | 453,542 | 436,598 | 2576.71% | 17,084,908,000 | Jun 30, 2024 |
| FIERA CAPITAL CORP | 1.76% | 0.15% | 1,297,302 | 380,027 | 41.43% | 48,869,366 | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 0.44% | 0.07% | 327,845 | 327,845 | 100.00% | 12,631,867 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.71% | 0.12% | 522,104 | 321,476 | 160.23% | 19,666,740 | Jun 30, 2024 |
| NORGES BANK | 0.38% | 0.00% | 280,343 | 280,343 | 100.00% | 10,560,521 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 5.02% | 4.16% | 3,700,000 | 220,147 | 6.33% | 139,379,000 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.27% | 0.23% | 199,855 | 199,855 | 100.00% | 7,528,538 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.51% | 0.00% | 375,664 | 192,853 | 105.49% | 14,151,262 | Jun 30, 2024 |
| SOROS FUND MANAGEMENT LLC | 0.52% | 0.26% | 385,000 | 181,054 | 88.78% | 14,502,950 | Jun 30, 2024 |
| BLACKROCK INC. | 7.62% | 0.00% | 5,619,260 | 180,403 | 3.32% | 211,677,525 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.26% | 0.02% | 194,155 | 178,050 | 1105.56% | 7,313,819 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.26% | 0.01% | 195,396 | 171,202 | 707.62% | 7,360,567 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.96% | 0.01% | 708,383 | 150,762 | 27.04% | 26,684,781 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.19% | 0.09% | 140,441 | 140,441 | 100.00% | 5,290,412 | Jun 30, 2024 |
| STATE STREET CORP | 4.18% | 0.01% | 3,086,845 | 125,221 | 4.23% | 116,281,451,000 | Jun 30, 2024 |
As of Jun 30 2024, SpringWorks Therapeutics's largest institutional buyer is DUQUESNE FAMILY OFFICE LLC. The company purchased 1.02M stocks of SWTX, valued at $38.48M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -1,283,176 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.02% | 0.00% | 14,714 | -690,825 | -97.91% | 554,276 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 3.16% | 0.12% | 2,333,117 | -633,505 | -21.35% | 87,888,517 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.24% | 1.48% | 1,652,962 | -609,500 | -26.94% | 62,267,079 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.88% | 0.02% | 3,602,234 | -508,228 | -12.36% | 135,697,000 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -426,768 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.38% | 0.00% | 280,126 | -262,907 | -48.41% | 10,552,346 | Jun 30, 2024 |
| MORGAN STANLEY | 0.44% | 0.00% | 326,119 | -254,943 | -43.88% | 12,284,955 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 2.81% | 0.26% | 2,073,970 | -243,840 | -10.52% | 78,126,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.07% | 0.00% | 786,896 | -238,936 | -23.29% | 29,642,370 | Jun 30, 2024 |
| ORACLE INVESTMENT MANAGEMENT INC | 0.32% | 8.20% | 233,200 | -188,383 | -44.68% | 8,784,644 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -128,000 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.36% | 0.12% | 263,340 | -108,734 | -29.22% | 9,920,018 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.78% | 1.26% | 1,313,026 | -102,322 | -7.23% | 49,461,689 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.19% | 0.03% | 140,106 | -102,067 | -42.15% | 5,277,791 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 2.20% | 0.73% | 1,624,991 | -97,386 | -5.65% | 61,213,411 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.23% | 0.01% | 173,284 | -80,348 | -31.68% | 6,527,608 | Jun 30, 2024 |
| UBS GROUP AG | 0.18% | 0.00% | 135,604 | -77,929 | -36.50% | 5,108,202 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.13% | 0.01% | 830,522 | -75,214 | -8.30% | 31,285,454 | Jun 30, 2024 |
As of Jun 30 2024, SpringWorks Therapeutics's biggest institutional seller is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). The company sold -1.28M shares of SWTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DUQUESNE FAMILY OFFICE LLC | 1.38% | 1.32% | 1,021,367 | 1,021,367 | 100.00% | 38,475,000 | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 0.44% | 0.07% | 327,845 | 327,845 | 100.00% | 12,631,867 | Jun 30, 2024 |
| NORGES BANK | 0.38% | 0.00% | 280,343 | 280,343 | 100.00% | 10,560,521 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.27% | 0.23% | 199,855 | 199,855 | 100.00% | 7,528,538 | Jun 30, 2024 |
| SEGALL BRYANT & HAMILL, LLC | 0.19% | 0.09% | 140,441 | 140,441 | 100.00% | 5,290,412 | Jun 30, 2024 |
| MAN GROUP PLC | 0.08% | 0.01% | 56,091 | 56,091 | 100.00% | 2,112,948 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 40,036 | 40,036 | 100.00% | 1,507,335 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 36,984 | 36,984 | 100.00% | 1,393,187 | Jun 30, 2024 |
| GUGGENHEIM CAPITAL LLC | 0.03% | 0.01% | 19,185 | 19,185 | 100.00% | 722,699 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.05% | 16,491 | 16,491 | 100.00% | 621,216 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 0.02% | 0.01% | 13,338 | 13,338 | 100.00% | 502,442 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 12,437 | 12,437 | 100.00% | 468,501 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.02% | 0.00% | 11,291 | 11,291 | 100.00% | 425,331 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.01% | 0.00% | 10,421 | 10,421 | 100.00% | 392,559 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | 0.00% | 3,278 | 3,278 | 100.00% | 123,482 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.00% | 0.00% | 2,409 | 2,409 | 100.00% | 90,000 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | 0.00% | 0.00% | 512 | 512 | 100.00% | 19,287 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 346 | 346 | 100.00% | 13,034 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 345 | 345 | 100.00% | 12,996 | Jun 30, 2024 |
| SYSTM WEALTH SOLUTIONS LLC | 0.00% | 0.00% | 255 | 255 | 100.00% | 9,606 | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.00% | 0.00% | 130 | 130 | 100.00% | 4,897 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 120 | 120 | 100.00% | 4,503 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 81 | 81 | 100.00% | 3,052 | Jun 30, 2024 |
| ITAU UNIBANCO HOLDING S.A. | - | - | 32 | 32 | 100.00% | 1,205 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 32 | 32 | 100.00% | 1,205 | Jun 30, 2024 |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | - | 0.00% | 18 | 18 | 100.00% | 678 | Jun 30, 2024 |
SpringWorks Therapeutics's largest new institutional shareholder by number of shares is DUQUESNE FAMILY OFFICE LLC, purchased 1.02M shares, valued at $38.48M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -1,283,176 | -100.00% | - | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -426,768 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -128,000 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -70,000 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -68,667 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -54,000 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -52,048 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -40,733 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -33,751 | -100.00% | - | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | - | - | - | -18,080 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -16,644 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -15,034 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -14,685 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -8,260 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -8,100 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -7,248 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SECURITY ADVISOR, INC. | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -4,894 | -100.00% | - | Jun 30, 2024 |
| BAYSHORE ASSET MANAGEMENT, LLC | - | - | - | -4,852 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -4,673 | -100.00% | - | Jun 30, 2024 |
| XPONANCE, INC. | - | - | - | -4,164 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -4,137 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -4,075 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,670 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -2,800 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -2,123 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -288 | -100.00% | - | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| HOLLENCREST CAPITAL MANAGEMENT | - | - | - | -98 | -100.00% | - | Jun 30, 2024 |
| WESTEND CAPITAL MANAGEMENT, LLC | - | - | - | -28 | -100.00% | - | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | - | - | - | -23 | -100.00% | - | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | - | - | - | -20 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
SpringWorks Therapeutics's largest sold out institutional shareholder by shares sold is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), sold -1.28M shares, valued at -, as of undefined.
SpringWorks Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Fiera Capital Series Trust | 1.08% | 21,513 | 5,143 | 31.42% | Jun 30, 2023 |
| Voya VARIABLE PRODUCTS TRUST | 0.59% | 212,914 | 212,914 | - | Mar 31, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.56% | 518,300 | 379,945 | 274.62% | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.45% | 1,498,085 | 447,960 | 42.66% | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.29% | 1,429,340 | 471,689 | 49.25% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.20% | 5,619,265 | 618,484 | 12.37% | Feb 29, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.17% | 344,382 | - | - | Feb 29, 2024 |
| MERIDIAN FUND INC | 0.14% | 328,832 | -114,009 | -25.74% | Mar 28, 2024 |
| Tema ETF Trust | 0.12% | 5,370 | 5,370 | - | Feb 29, 2024 |
| Voya EQUITY TRUST | 0.10% | 149,068 | 149,068 | - | Feb 29, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.07% | 219,945 | 98,622 | 81.29% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 35,106 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.05% | 649,666 | -54,451 | -7.73% | Jan 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.04% | 42,581 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.04% | 70,220 | 20,400 | 40.95% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.03% | 85,732 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.03% | 13,440 | 3,610 | 36.72% | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.03% | 3,102 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 118,476 | -3,654 | -2.99% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 153,600 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,153 | -118 | -1.15% | Mar 31, 2024 |
| MFS SERIES TRUST I | 0.02% | 307,648 | 39,629 | 14.79% | Feb 29, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.02% | 66,072 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 114,100 | 114,100 | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 5,716,153 | -490,754 | -7.91% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 238 | - | - | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 649,709 | 221,298 | 51.66% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,868 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 25,620 | 403 | 1.60% | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 9,406 | 5,816 | 162.01% | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.01% | 191,330 | 53,120 | 38.43% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 46,037 | - | - | Mar 28, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 183,066 | 23,719 | 14.89% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 44,517 | 321 | 0.73% | Feb 29, 2024 |
| MFS VARIABLE INSURANCE TRUST | 0.00% | 90,463 | 506 | 0.56% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 591,704 | 90,103 | 17.96% | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 19,632 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,947 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 127,658 | -29,710 | -18.88% | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 15,681 | - | - | Dec 31, 2023 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 81,047 | 18,739 | 30.07% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 6,511 | - | - | Jan 31, 2024 |
| Thrivent Core Funds | 0.00% | 94,155 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 41,454 | 425 | 1.04% | Mar 31, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.00% | 268,322 | 268,322 | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 24,539 | 10,020 | 69.01% | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 4,700 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 138,595 | -2,419 | -1.72% | Jan 31, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 38,435 | -7,395 | -16.14% | Mar 28, 2024 |
| ProFunds | 0.00% | 9,646 | 979 | 11.30% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 53,260 | -12,492 | -19.00% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 9,100 | 6,236 | 217.74% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 739,439 | 90,779 | 13.99% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 172,224 | 44,749 | 35.10% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 22,082 | -4,768 | -17.76% | Mar 31, 2024 |
| Global X Funds | 0.00% | 30,343 | 3,900 | 14.75% | Jan 31, 2024 |
| Federated Hermes Adviser Series | 0.00% | 4,200 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,252 | -64 | -1.93% | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 4,010 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,738 | -636 | -7.59% | Mar 31, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 40,168 | 36,430 | 974.59% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 267,499 | 5,349 | 2.04% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 329,022 | 58,447 | 21.60% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,052 | -4,899 | -70.48% | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 6,260 | -240 | -3.69% | Mar 31, 2023 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 4,446 | 4,446 | - | Mar 28, 2024 |
| AMG FUNDS III | 0.00% | 2,342 | - | - | Mar 28, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 2,044 | 1,357 | 197.53% | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 89,813 | 24,116 | 36.71% | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 8,324 | 8,324 | - | Mar 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 41,123 | 41,123 | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 890 | -7,404 | -89.27% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 7,122 | -10,748 | -60.15% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 24,645 | 545 | 2.26% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 2,228 | - | - | Aug 31, 2023 |
| SunAmerica Specialty Series | 0.00% | 175 | - | - | Apr 30, 2021 |
| Voya INVESTORS TRUST | 0.00% | 18,267 | -1,354 | -6.90% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 896 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 6,261 | 1,002 | 19.05% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 26,672 | - | - | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 1,714 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 75,830 | 7,306 | 10.66% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 6,089 | -338 | -5.26% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 31,928 | 9,137 | 40.09% | Mar 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 1,573 | 1,573 | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 64,333 | 998 | 1.58% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 29,589 | 522 | 1.80% | Mar 28, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 6,534 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 952 | - | - | Mar 31, 2024 |
| Voya PARTNERS INC | 0.00% | 15,740 | -5,810 | -26.96% | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,101 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 2,829,767 | 1,908 | 0.07% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 191,754 | 5,437 | 2.92% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 308,988 | 73,975 | 31.48% | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.00% | 148,984 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 610 | 78 | 14.66% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES I | 0.00% | 23,000 | 23,000 | - | Mar 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 70,201 | -3,465 | -4.70% | Mar 31, 2024 |
| LOOMIS SAYLES FUNDS II | 0.00% | 304,505 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 12,034 | - | - | Mar 28, 2024 |
SpringWorks Therapeutics's largest mutual fund holder by % of total assets is "Fiera Capital Series Trust", owning 21.51K shares, compromising 1.08% of its total assets.
SpringWorks Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 73 | -67.98% |
| 31 Mar, 24 | 228 | 23.24% |
| 31 Dec, 23 | 185 | 25.85% |
| 30 Sep, 23 | 147 | 2.80% |
| 30 Jun, 23 | 143 | -5.30% |
| 31 Mar, 23 | 151 | 4.14% |
| 31 Dec, 22 | 145 | -5.23% |
| 30 Sep, 22 | 153 | 5.52% |
| 30 Jun, 22 | 145 | -5.84% |
| 31 Mar, 22 | 154 | 6.94% |
| 31 Dec, 21 | 144 | 0.70% |
| 30 Sep, 21 | 143 | 5.93% |
| 30 Jun, 21 | 135 | -0.74% |
| 31 Mar, 21 | 136 | 10.57% |
| 31 Dec, 20 | 123 | 33.70% |
| 30 Sep, 20 | 92 | 17.95% |
| 30 Jun, 20 | 78 | 13.04% |
| 31 Mar, 20 | 69 | 21.05% |
| 31 Dec, 19 | 57 | 29.55% |
| 30 Sep, 19 | 44 | 4300.00% |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | 1 | - |
As of 30 Jun 24, 73 institutions are holding SpringWorks Therapeutics's shares, representing a decrease of -67.98% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 8,154,109 | -89.53% |
| 31 Mar, 24 | 77,868,140 | 3.37% |
| 31 Dec, 23 | 75,327,577 | 10.52% |
| 30 Sep, 23 | 68,154,625 | -1.69% |
| 30 Jun, 23 | 69,323,797 | 4.66% |
| 31 Mar, 23 | 66,239,144 | -94.51% |
| 31 Dec, 22 | 1,207,447,738 | 1809.05% |
| 30 Sep, 22 | 63,248,752 | 14.40% |
| 30 Jun, 22 | 55,286,478 | 11.77% |
| 31 Mar, 22 | 49,466,058 | 8.86% |
| 31 Dec, 21 | 45,440,980 | 0.82% |
| 30 Sep, 21 | 45,070,464 | 0.75% |
| 30 Jun, 21 | 44,735,996 | 1.87% |
| 31 Mar, 21 | 43,913,347 | 1.24% |
| 31 Dec, 20 | 43,377,130 | 15.73% |
| 30 Sep, 20 | 37,482,223 | 7.69% |
| 30 Jun, 20 | 34,807,237 | 5.35% |
| 31 Mar, 20 | 33,039,184 | 3.32% |
| 31 Dec, 19 | 31,976,132 | 2.25% |
| 30 Sep, 19 | 31,271,148 | 57865.35% |
| 30 Jun, 19 | 53,948 | - |
| 31 Mar, 19 | 53,948 | - |
SpringWorks Therapeutics (SWTX) has 8.15M shares outstanding as of 30 Jun 24, down -89.53% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 11.05% | 0.10% |
| 31 Mar, 24 | 105.56% | 1.00% |
| 31 Dec, 23 | 102.50% | 0.86% |
| 30 Sep, 23 | 109.01% | 0.89% |
| 30 Jun, 23 | 110.98% | 0.98% |
| 31 Mar, 23 | 106.28% | 0.00% |
| 31 Dec, 22 | 2265.78% | 15.85% |
| 30 Sep, 22 | 119.56% | 0.94% |
| 30 Jun, 22 | 112.66% | 1.10% |
| 31 Mar, 22 | 101.08% | 1.16% |
| 31 Dec, 21 | 93.23% | 1.08% |
| 30 Sep, 21 | 92.75% | 1.09% |
| 30 Jun, 21 | 92.39% | 1.11% |
| 31 Mar, 21 | 91.05% | 1.08% |
| 31 Dec, 20 | 91.68% | 1.16% |
| 30 Sep, 20 | 88.93% | 1.29% |
| 30 Jun, 20 | 82.98% | 1.33% |
| 31 Mar, 20 | 79.06% | 1.43% |
| 31 Dec, 19 | 74.35% | 1.33% |
| 30 Sep, 19 | 74.66% | 450041.54% |
| 30 Jun, 19 | 0.13% | 217.98% |
| 31 Mar, 19 | 0.24% | - |
As of 30 Jun 24, SpringWorks Therapeutics is held by 11.05% institutional shareholders, representing a 0.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 41 | -71.33% |
| 31 Mar, 24 | 143 | 7.52% |
| 31 Dec, 23 | 133 | 84.72% |
| 30 Sep, 23 | 72 | -13.25% |
| 30 Jun, 23 | 83 | 12.16% |
| 31 Mar, 23 | 74 | -13.95% |
| 31 Dec, 22 | 86 | 3.61% |
| 30 Sep, 22 | 83 | -8.79% |
| 30 Jun, 22 | 91 | 28.17% |
| 31 Mar, 22 | 71 | -11.25% |
| 31 Dec, 21 | 80 | 2.56% |
| 30 Sep, 21 | 78 | -2.50% |
| 30 Jun, 21 | 80 | 3.90% |
| 31 Mar, 21 | 77 | -18.09% |
| 31 Dec, 20 | 94 | 100.00% |
| 30 Sep, 20 | 47 | -18.97% |
| 30 Jun, 20 | 58 | 48.72% |
| 31 Mar, 20 | 39 | -2.50% |
| 31 Dec, 19 | 40 | -6.98% |
| 30 Sep, 19 | 43 | - |
| 30 Jun, 19 | - | -100.00% |
| 31 Mar, 19 | 1 | - |
41 institutional shareholders have increased their position in SWTX stock as of 30 Jun 24 compared to 143 in the previous quarter (a -71.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -65.45% |
| 31 Mar, 24 | 55 | 66.67% |
| 31 Dec, 23 | 33 | -26.67% |
| 30 Sep, 23 | 45 | 25.00% |
| 30 Jun, 23 | 36 | -35.71% |
| 31 Mar, 23 | 56 | 51.35% |
| 31 Dec, 22 | 37 | -13.95% |
| 30 Sep, 22 | 43 | 26.47% |
| 30 Jun, 22 | 34 | -24.44% |
| 31 Mar, 22 | 45 | 4.65% |
| 31 Dec, 21 | 43 | 13.16% |
| 30 Sep, 21 | 38 | 5.56% |
| 30 Jun, 21 | 36 | -21.74% |
| 31 Mar, 21 | 46 | 187.50% |
| 31 Dec, 20 | 16 | -46.67% |
| 30 Sep, 20 | 30 | 150.00% |
| 30 Jun, 20 | 12 | -33.33% |
| 31 Mar, 20 | 18 | 80.00% |
| 31 Dec, 19 | 10 | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | - |
| 31 Mar, 19 | - | - |
19 institutional shareholders have reduced their position in SWTX stock as of 30 Jun 24 compared to 55 in the previous quarter (a -65.45% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 73 | -67.98% | 8,154,109 | -89.53% | 11.05% | 0.10% | 41 | -71.33% | 19 | -65.45% |
| 31 Mar, 24 | 228 | 23.24% | 77,868,140 | 3.37% | 105.56% | 1.00% | 143 | 7.52% | 55 | 66.67% |
| 31 Dec, 23 | 185 | 25.85% | 75,327,577 | 10.52% | 102.50% | 0.86% | 133 | 84.72% | 33 | -26.67% |
| 30 Sep, 23 | 147 | 2.80% | 68,154,625 | -1.69% | 109.01% | 0.89% | 72 | -13.25% | 45 | 25.00% |
| 30 Jun, 23 | 143 | -5.30% | 69,323,797 | 4.66% | 110.98% | 0.98% | 83 | 12.16% | 36 | -35.71% |
| 31 Mar, 23 | 151 | 4.14% | 66,239,144 | -94.51% | 106.28% | 0.00% | 74 | -13.95% | 56 | 51.35% |
| 31 Dec, 22 | 145 | -5.23% | 1,207,447,738 | 1809.05% | 2265.78% | 15.85% | 86 | 3.61% | 37 | -13.95% |
| 30 Sep, 22 | 153 | 5.52% | 63,248,752 | 14.40% | 119.56% | 0.94% | 83 | -8.79% | 43 | 26.47% |
| 30 Jun, 22 | 145 | -5.84% | 55,286,478 | 11.77% | 112.66% | 1.10% | 91 | 28.17% | 34 | -24.44% |
| 31 Mar, 22 | 154 | 6.94% | 49,466,058 | 8.86% | 101.08% | 1.16% | 71 | -11.25% | 45 | 4.65% |
| 31 Dec, 21 | 144 | 0.70% | 45,440,980 | 0.82% | 93.23% | 1.08% | 80 | 2.56% | 43 | 13.16% |
| 30 Sep, 21 | 143 | 5.93% | 45,070,464 | 0.75% | 92.75% | 1.09% | 78 | -2.50% | 38 | 5.56% |
| 30 Jun, 21 | 135 | -0.74% | 44,735,996 | 1.87% | 92.39% | 1.11% | 80 | 3.90% | 36 | -21.74% |
| 31 Mar, 21 | 136 | 10.57% | 43,913,347 | 1.24% | 91.05% | 1.08% | 77 | -18.09% | 46 | 187.50% |
| 31 Dec, 20 | 123 | 33.70% | 43,377,130 | 15.73% | 91.68% | 1.16% | 94 | 100.00% | 16 | -46.67% |
| 30 Sep, 20 | 92 | 17.95% | 37,482,223 | 7.69% | 88.93% | 1.29% | 47 | -18.97% | 30 | 150.00% |
| 30 Jun, 20 | 78 | 13.04% | 34,807,237 | 5.35% | 82.98% | 1.33% | 58 | 48.72% | 12 | -33.33% |
| 31 Mar, 20 | 69 | 21.05% | 33,039,184 | 3.32% | 79.06% | 1.43% | 39 | -2.50% | 18 | 80.00% |
| 31 Dec, 19 | 57 | 29.55% | 31,976,132 | 2.25% | 74.35% | 1.33% | 40 | -6.98% | 10 | - |
| 30 Sep, 19 | 44 | 4300.00% | 31,271,148 | 57865.35% | 74.66% | 450041.54% | 43 | - | - | - |
| 30 Jun, 19 | 1 | - | 53,948 | - | 0.13% | 217.98% | - | -100.00% | - | - |
| 31 Mar, 19 | 1 | - | 53,948 | - | 0.24% | - | 1 | - | - | - |
SpringWorks Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of SpringWorks Therapeutics's stock was made by Cassidy James on Jul 02 2024, selling 591 shares at $38.53 per share (valued at $22.77K).
SpringWorks Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 1 | 200.00% |
| Q2 2024 | 10 | 13 | 76.92% |
| Q1 2024 | 22 | 30 | 73.33% |
| Q4 2023 | 3 | - | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | 14 | 2 | 700.00% |
| Q1 2023 | 25 | 19 | 131.58% |
| Q4 2022 | 1 | 3 | 33.33% |
| Q3 2022 | 1 | 7 | 14.29% |
| Q2 2022 | 15 | 2 | 750.00% |
| Q1 2022 | 18 | 14 | 128.57% |
| Q4 2021 | 1 | 5 | 20.00% |
| Q3 2021 | 2 | 8 | 25.00% |
| Q2 2021 | 17 | 16 | 106.25% |
| Q1 2021 | 18 | 8 | 225.00% |
| Q4 2020 | - | - | - |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 6 | - | - |
| Q1 2020 | 7 | - | - |
| Q4 2019 | 1 | - | - |
2 total buy trades, and 1 total sell trades (buy/sell ratio of 2.00%) were made by SpringWorks Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 12 | - |
| Q1 2024 | - | 10 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 3 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 4 | - |
| Q3 2021 | - | 6 | - |
| Q2 2021 | - | 15 | - |
| Q1 2021 | - | 6 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of SpringWorks Therapeutics's stocks.
SpringWorks Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| SANA | Sana Biotechnology, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| ARVN | Arvinas, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| RNA | Avidity Biosciences, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| PASG | Passage Bio, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
SWTX Ownership FAQ
Who Owns SpringWorks Therapeutics?
SpringWorks Therapeutics is owned by institutional shareholders (11.05%), insiders (2.02%), and public (86.93%). The largest institutional shareholder of SpringWorks Therapeutics is FMR LLC (15.06% of total shares) and the top mutual fund owner is Fiera Capital Series Trust (1.08% of total shares).
Who are the major institutional shareholders of SpringWorks Therapeutics?
SpringWorks Therapeutics's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, BLACKROCK INC., DEEP TRACK CAPITAL, LP, and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 41.45% of the company's share outstanding.
How many SpringWorks Therapeutics shareholders are there?
As of Jun 2024, there are 73 institutional shareholders of SpringWorks Therapeutics.
What percentage of SpringWorks Therapeutics is owned by FMR LLC?
FMR LLC owns 11.11M shares of SpringWorks Therapeutics, representing 15.06% of the company's total shares outstanding, valued at $418.6M (as of Jun 2024).
What percentage of SpringWorks Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 6.54M shares of SpringWorks Therapeutics (SWTX), compromising 8.87% of the company, valued at $246.53M.
What percentage of SpringWorks Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of SpringWorks Therapeutics. The company owns 5.62M of the company's shares outstanding (worth $211.68M).